SCHEMBL7926749

SCHEMBL7926749

CCCC(C(C)(C(=O)O)c1ccc2ccccc2c1)P(=O)(O)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 7/20 0.43
PPARG P37231 2/20 0.41
PPARA Q07869 2/20 0.41
MMP1 P03956 1/20 0.37
CETP P11597 1/20 0.36
UBE2M P61081 1/20 0.36
DCUN1D1 Q96GG9 1/20 0.36
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
KCNH2 Q12809 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KIF11 P52732 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7931915 0.78 CETP (0.41) PTPN1PPARGPPARACETPSLC6A2
SCHEMBL7919970 0.76 PTPN1 (0.42) PTPN1PPARGPPARASLC6A2SLC6A4
SCHEMBL7931864 0.76 PTPN1 (0.44) PTPN1PPARGPPARACETPSLC6A2
SCHEMBL7929207 0.76 PTPN1 (0.41) PTPN1PPARGPPARACETPNPC1
SCHEMBL7920074 0.74 DRD2 (0.39) PPARGPPARACETP
SCHEMBL7607399 0.74 PTPN1 (0.47) PTPN1MMP1CETPNPC1RAB9A
SCHEMBL7610504 0.73 PTPN1 (0.49) PTPN1MMP1SLC6A2SLC6A4SLC6A3
SCHEMBL7610440 0.73 PTPN1 (0.46) PTPN1MMP1CETPSLC6A2SLC6A4
SCHEMBL7609842 0.73 PTPN1 (0.43) PTPN1MMP1CETPNPC1RAB9A
SCHEMBL7604018 0.72 PTPN1 (0.48) PTPN1PPARGNPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994707-A4 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARM INC (US) 2001-11-14 EP claimed
EP-0994707-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 2000-04-26 EP claimed
WO-1998053812-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1998-12-03 WO claimed
EP-0994707-A4 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARM INC (US) 2001-11-14 EP disclosed
EP-0994707-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 2000-04-26 EP disclosed
WO-1998053812-A1 INHIBITORS OF NAALADASE ENZYME ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1998-12-03 WO disclosed